Bellon Christine
SEC CIK 1963878 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | CLO | 109.7K | — | $1.90M | 21 | 2023-03-30 | 2026-04-01 |
Most active insiders at BEAM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FMR LLC | 10%, See Remark 1 | — | $10.05M |
| 2 | Evans John M. | CEO, Dir | — | $6.28M |
| 3 | Ciaramella Giuseppe | Pres | — | $1.41M |
| 4 | Bellon Christine | CLO | — | $881.0K |
| 5 | Simon Amy | Chief Medical Off | — | $606.7K |
| 6 | Cavanagh Bethany J | SVP, Fin, Treas | — | $399.5K |
| 7 | Emany Sravan Kumar | CFO | — | $170.6K |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-06 17:39 | 2026-04-01 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $24.58 | -5,956 | 109.7K | -5% | -$146.4K |
| 2026-04-02 17:27 | 2026-03-31 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | A - Grant | $0.00 | +20.0K | 115.7K | +21% | $0 | |
| T | 2026-01-26 | 2026-01-22 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $34.00 | -1,371 | 95.7K | -1% | -$46.6K |
| MT | 2026-01-20 | 2026-01-15 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $34.62 | -18.6K | 97.0K | -16% | -$644.9K |
| T | 2026-01-05 | 2025-12-31 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $27.10 | -1,254 | 115.7K | -1% | -$34.0K |
| T | 2025-10-03 | 2025-10-01 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $24.53 | -373 | 116.9K | -0.3% | -$9,150 |
| T | 2025-04-03 | 2025-04-01 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $18.35 | -5,674 | 117.3K | -5% | -$104.1K |
| 2025-04-02 | 2025-03-31 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | A - Grant | $0.00 | +20.0K | 123.0K | +19% | $0 | |
| DT | 2025-02-19 | 2025-02-14 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale+OE | $34.00 | -10.0K | 103.0K | -9% | -$340.0K |
| DMT | 2025-02-19 | 2025-02-14 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | M - OptEx | $7.22 | +10.0K | 112.5K | +10% | +$72.2K |
| T | 2025-01-06 | 2025-01-02 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $24.68 | -1,241 | 103.0K | -1% | -$30.6K |
| T | 2024-10-02 | 2024-10-01 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $23.48 | -385 | 104.2K | -0.4% | -$9,040 |
| T | 2024-04-03 | 2024-04-01 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $32.12 | -3,401 | 104.6K | -3% | -$109.2K |
| 2024-04-02 | 2024-03-31 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | A - Grant | $0.00 | +27.5K | 108.0K | +34% | $0 | |
| T | 2024-01-05 | 2024-01-03 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $26.42 | -1,907 | 80.5K | -2% | -$50.4K |
| DMT | 2023-11-22 | 2023-11-20 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale+OE | $30.50 | -10.0K | 87.4K | -10% | -$305.0K |
| DMT | 2023-11-22 | 2023-11-20 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | M - OptEx | $7.22 | +10.0K | 86.6K | +13% | +$72.2K |
| T | 2023-10-04 | 2023-10-02 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $22.85 | -388 | 82.4K | -0.5% | -$8,866 |
| M | 2023-04-05 | 2023-04-03+ | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | S - Sale | $29.63 | -2,092 | 82.8K | -2% | -$62.0K |
| D | 2023-03-31 | 2023-03-31 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | A - Grant | $0.00 | +17.5K | 84.9K | +26% | $0 |
| DM | 2023-03-31 | 2023-03-30 | BEAM | Beam Therapeutics Inc. | Bellon Christine | CLO | M - OptEx | $7.22 | +8,941 | 67.4K | +15% | +$64.6K |
Purchase Sale Sale after option exercise All abbreviations